IL46485A0 - Pharmaceutical compositions for preventing thrombosis comprising condensed pyrrole derivatives - Google Patents
Pharmaceutical compositions for preventing thrombosis comprising condensed pyrrole derivativesInfo
- Publication number
- IL46485A0 IL46485A0 IL46485A IL4648575A IL46485A0 IL 46485 A0 IL46485 A0 IL 46485A0 IL 46485 A IL46485 A IL 46485A IL 4648575 A IL4648575 A IL 4648575A IL 46485 A0 IL46485 A0 IL 46485A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- pyrrole derivatives
- preventing thrombosis
- condensed pyrrole
- condensed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US436796A US3904761A (en) | 1974-01-25 | 1974-01-25 | Method of preventing thrombosis |
Publications (1)
Publication Number | Publication Date |
---|---|
IL46485A0 true IL46485A0 (en) | 1976-10-31 |
Family
ID=23733865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL46485A IL46485A0 (en) | 1974-01-25 | 1975-01-21 | Pharmaceutical compositions for preventing thrombosis comprising condensed pyrrole derivatives |
Country Status (6)
Country | Link |
---|---|
US (1) | US3904761A (en) |
DE (1) | DE2502156C2 (en) |
GB (1) | GB1499720A (en) |
IL (1) | IL46485A0 (en) |
NL (1) | NL7500861A (en) |
ZA (1) | ZA75519B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU843739A3 (en) * | 1978-02-17 | 1981-06-30 | Карл Томэ Гмбх (Фирма) | Method of preparing carbostyryl or oxyindole derivatives |
US4442111A (en) * | 1981-07-25 | 1984-04-10 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Antithrombotic sulfimino and sulfoximino indolinones-2 |
US5401730A (en) * | 1990-07-06 | 1995-03-28 | The Hope Heart Institute | Method for reducing platelet aggregation |
US7678823B2 (en) * | 2004-10-04 | 2010-03-16 | Myriad Pharmaceticals, Inc. | Compounds for alzheimer's disease |
US9216966B2 (en) | 2004-10-04 | 2015-12-22 | John Manfredi | Compounds for Alzheimer's disease |
KR101213495B1 (en) | 2010-06-03 | 2013-01-14 | 삼성디스플레이 주식회사 | Organic light emitting device |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3687971A (en) * | 1970-06-22 | 1972-08-29 | Merck & Co Inc | 4-(pyrrolyl)-salicylic acid derivatives |
-
1974
- 1974-01-25 US US436796A patent/US3904761A/en not_active Expired - Lifetime
-
1975
- 1975-01-21 DE DE2502156A patent/DE2502156C2/en not_active Expired
- 1975-01-21 IL IL46485A patent/IL46485A0/en unknown
- 1975-01-24 GB GB3252/75A patent/GB1499720A/en not_active Expired
- 1975-01-24 ZA ZA00750519A patent/ZA75519B/en unknown
- 1975-01-24 NL NL7500861A patent/NL7500861A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA75519B (en) | 1976-01-28 |
GB1499720A (en) | 1978-02-01 |
NL7500861A (en) | 1975-07-29 |
DE2502156A1 (en) | 1975-10-30 |
DE2502156C2 (en) | 1985-05-30 |
US3904761A (en) | 1975-09-09 |
AU7760375A (en) | 1976-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA751806B (en) | Pharmaceutical compositions | |
ZA7671B (en) | Pharmaceutical composition | |
JPS5272829A (en) | Pharmaceutical composition | |
ZA74385B (en) | Pharmaceutical compositions | |
ZA763917B (en) | Pharmaceutical compositions and compounds | |
ZA755998B (en) | Pharmaceutical compositions | |
IL48508A (en) | Pharmaceutical compositions comprising piperidylindole derivatives | |
CY1153A (en) | Pharmaceutical compositions | |
IL46485A0 (en) | Pharmaceutical compositions for preventing thrombosis comprising condensed pyrrole derivatives | |
MY8100372A (en) | Pharmaceutical compositions | |
NZ179502A (en) | Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition | |
ZA755802B (en) | Pharmaceutical compositions | |
ZA761012B (en) | Pharmaceutical compositions | |
ZA767215B (en) | Pharmaceutical compositions | |
GB1552416A (en) | Pharmaceutical compositions | |
IL48098A0 (en) | Pharmaceutical compositions containing diphenylethanol derivatives | |
ZA761880B (en) | New pharmaceutical compositions | |
HK73178A (en) | Pharmaceutical compositions | |
PH12855A (en) | Pharmaceutical compositions | |
ZA763806B (en) | Pharmaceutical compositions | |
IL51043A0 (en) | Novel pharmaceutical compositions comprising ergot-type compounds | |
IE43955L (en) | Pharmaceutical composition | |
AU1172076A (en) | Pharmaceutical compositions | |
IL49355A0 (en) | Pharmaceutical compositions comprising sodium-l-ascorbate-2-sulfate | |
ZA752585B (en) | Pharmaceutical composition |